Kodiak Sciences (KOD) has been drawing attention after a strong 1 year total return of 531%, along with sizeable moves over the past 3 months and the last 7 days, prompting fresh questions about how investors might assess the stock today.

The average one-year price target for Gilead Sciences (NasdaqGS:GILD) has been revised to $159.01 / share. This is an increase of 11.73% from the prior estimate of $142.32 dated February 1, 2026. The price target is an average of many targets provided by analysts.

By Rishika Sadam MUMBAI, Feb 20 (Reuters) - Indian drug manufacturer Sai Life Sciences plans to raise its headcount by more than 700 people, or about 20%, next financial year as it scales up capacity to meet rising global demand,

Airflow Sciences Corporation has been awarded $1.15 Million from the U.S. Department of Energy to develop a specialized

New peptide research blend shows promise as a game-changer in the fitness space BURTON, MI, UNITED STATES, January 19,

The Wiley Foundation honored research into connectomes — detailed atlases of the brain that map out thousands of neurons and the millions of connection between them.

Following a difficult start in 2025, the ever-evolving life sciences segment recovered strongly in the latter half of the year.

Students, young professionals, and industry leaders invited to explore emerging GIS trends and network with innovators

Exact Sciences (NASDAQ:EXAS) held a special meeting of stockholders on February 20, 2026, to vote on proposals related to its previously announced merger agreement with Abbott Laboratories. Kevin Conroy,